Skip to main content
Screener/Healthcare/Medical - Diagnostics & Research

GRAL — GRAIL, Inc.

NASDAQ
$59.18-0.63 (-1.05%)
Mid CapHealthcareFastest GrowingHigh Beta
$29.95
$118.84
$57.12
$60.60
EPS (TTM)$-10.37
P/E Ratio-5.21
Dividend Yield—
Market Cap$2.51B
Volume291K
Prev Close$59.81
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$40.8M-$93.2M$-2.2947.9%-228.5%
Q4 '25$43.6M-$99.2M$-2.44-25.5%-227.5%
Q3 '25$36.2M-$89.0M$-2.46-37.9%-245.8%
Q2 '25$35.5M-$114.0M$-3.18-50.0%-320.7%
Q1 '25$31.8M-$106.2M$-3.10-62.6%-333.6%
Q4 '24$38.3M-$97.1M$-2.89-41.7%-253.8%
Q3 '24$28.7M-$125.7M$-3.94-77.6%-438.7%
Q2 '24$32.0M-$1.6B$-51.06-56.0%-4958.8%
Get Your Daily Market Recap